UK Markets open in 1 hr 50 mins

Moderna, Inc. (MRNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
120.99+2.74 (+2.32%)
At close: 04:00PM EDT
120.88 -0.11 (-0.09%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 46.19B
Enterprise value 39.18B
Trailing P/E 3.60
Forward P/E 20.66
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.27
Price/book (mrq)2.57
Enterprise value/revenue 1.76
Enterprise value/EBITDA 2.45

Trading information

Stock price history

Beta (5Y monthly) 1.65
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3376.65
52-week low 3115.03
50-day moving average 3146.84
200-day moving average 3159.98

Share statistics

Avg vol (3-month) 34.82M
Avg vol (10-day) 34.41M
Shares outstanding 5405.45M
Implied shares outstanding 6N/A
Float 8360.03M
% held by insiders 19.41%
% held by institutions 164.21%
Shares short (14 Jul 2022) 416.29M
Short ratio (14 Jul 2022) 42.87
Short % of float (14 Jul 2022) 45.49%
Short % of shares outstanding (14 Jul 2022) 44.09%
Shares short (prior month 14 Jun 2022) 414.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 64.77%
Operating margin (ttm)71.93%

Management effectiveness

Return on assets (ttm)50.42%
Return on equity (ttm)139.99%

Income statement

Revenue (ttm)22.6B
Revenue per share (ttm)56.01
Quarterly revenue growth (yoy)213.20%
Gross profit (ttm)13.86B
EBITDA 16.55B
Net income avi to common (ttm)14.64B
Diluted EPS (ttm)-1.96
Quarterly earnings growth (yoy)199.50%

Balance sheet

Total cash (mrq)10.12B
Total cash per share (mrq)25.43
Total debt (mrq)947M
Total debt/equity (mrq)5.55
Current ratio (mrq)1.77
Book value per share (mrq)6.42

Cash flow statement

Operating cash flow (ttm)13.41B
Levered free cash flow (ttm)8.59B